Catalyst Pharmaceuticals, Inc. logo CPRX - Catalyst Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 13
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $32.00 DETAILS
HIGH: $32.00
LOW: $32.00
MEDIAN: $32.00
CONSENSUS: $32.00
UPSIDE: 2.37%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

A- 80.9 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — no stock price or analyst input.

Profitability

Weight: 25%
B- 66.6
  • 5yr Avg ROIC 11.0% 65/100
  • Operating Margin Trend +0.53 pp/yr 71/100
Contributes 16.7 pts toward composite.

Capital Efficiency

Weight: 15%
C- 48.1
  • 5yr Avg ROE 12.0% 70/100
  • 5yr Share-Count CAGR 4.2% 8/100
Contributes 7.2 pts toward composite.

Growth Quality

Weight: 25%
A+ 100.0
  • 5yr Revenue CAGR 43.0% 100/100
  • 5yr EPS CAGR 46.0% 100/100
  • Revenue-Growth Years (5) 5/5 100/100
Contributes 25.0 pts toward composite.

Cash Generation

Weight: 20%
A+ 98.2
  • 5yr FCF Margin 39.2% 100/100
  • 5yr FCF/NI Conversion 1.24x 96/100
Contributes 19.6 pts toward composite.

Balance Sheet

Weight: 10%
A+ 100.0
  • Net Debt / EBITDA -2.39x 100/100
  • Interest Coverage (EBIT/Int) 30.00x 100/100
  • Altman Z-Score 19.81 100/100
Contributes 10.0 pts toward composite.

Stability

Weight: 5%
C- 47.9
  • EPS Volatility (σ/μ) 0.61 21/100
  • Piotroski F-Score 4 44/100
  • Negative-Revenue Years (5) 0/5 100/100
Contributes 2.4 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

4 of 4 gurus held; 1 new buy; 1 added; 2 trimmed.

Holders
4 +1
Avg Δ position
+66.7%
New buys
1
Full exits
0
As of Q1 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Piotroski F-Score, Negative-Revenue Years (5)

We deliberately ignore stock price, analyst targets, and consensus ratings so the grade is suitable for backtesting forward returns. A minimum of 5 fiscal years of audited statements is required; distressed and highly leveraged infrastructure businesses are declared ungradable rather than forced into a numeric score.